drugset / Trial / NCT00621790

Fenoldopam and Acute Renal Failure

NCT00621790 ↗

Phase 3 Completed 667 enrolled Vita-Salute San Raffaele University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients undergoing cardiac surgery could develop postoperative acute renal failure requiring renal replacement therapy. Fenoldopam, already used for patients with hypertensive emergencies, could improve renal function in critically ill patients with or at risk for acute renal failure.

Timeline

Start
2008-02
Primary completion
2013-06
Completion
2013-06

Outcome

Missed primary endpoint

paper Sixty-nine of 338 patients (20%) allocated to the fenoldopam group and 60 of 329 patients (18%) allocated to the placebo group received renal replacement therapy (P = .47). PMID 25265449 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenoldopam Small molecule 0.1 ug/kg —

Indications